The need for additional studies is highlighted by the differential effects of IL-4 administration in RA models, with IL-4 administration being able to attenuate proteoglycan induced arthritis by means of inhibiting pro-inflammatory cytokine production, although having no disease modulating effect in collagen induced arthritis mice. The gene discussed is IL4; the disease is rheumatoid arthritis.